Basic research on the biology of meta-tetra(hydroxyphenyl) chlorin for photodynamic therapy in gynaecology: Somatic genotoxicity assayed withDrosophila melanogaster

The well-established SMART test, a somatic mutation and recombination assay of Drosophila, was applied to assess the possible genotoxicity of sublethal meta-tetra(hydroxyphenyl) chlorin (mTHPC) photodynamic therapy (PDT) to clonogenic cells in situ. The SMART assay monitors the loss of heterozygosit...

Full description

Saved in:
Bibliographic Details
Published in:Lasers in medical science 1997-10, Vol.12 (3), p.280-284
Main Authors: Schweizer, P M, Walt, H, Fehr, M, Haller, U
Format: Article
Language:English
Subjects:
Assaying
Biology
Drosophila
Genotoxicity
Lasers
Loci
Monitors
Photodynamic therapy
Uptakes
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The well-established SMART test, a somatic mutation and recombination assay of Drosophila, was applied to assess the possible genotoxicity of sublethal meta-tetra(hydroxyphenyl) chlorin (mTHPC) photodynamic therapy (PDT) to clonogenic cells in situ. The SMART assay monitors the loss of heterozygosity (LOH) at selected cell-marker loci in clonogenic cells of the larval wing primordia. No evidence of genotoxicity was observed under conditions that killed between 38 and 86% of the exposed test larvae. Since the SMART assay is based on the oral uptake of the suspected genotoxic agent, the uptake kinetics of mTHPC by the assay's specific target cells must be known. Therefore, relevant studies are being carried out at present in order to draw final conclusions from this negative test result for genotoxicity.
ISSN:0268-8921
1435-604X
DOI:10.1007/BF02765110